Abstract | OBJECTIVE: METHODS: We pooled data from published studies reporting APOE genotype and MRI assessment of cSS in 3 distinct settings: (1) stroke clinic patients with symptomatic CAA (i.e., lobar intracerebral hemorrhage, transient focal neurologic episodes) according to the Boston criteria; (2) memory clinic patients; and (3) population-based studies. We compared cSS presence and severity (focal or disseminated vs no cSS) in participants with ε2+ or ε4+ genotype vs the ε3/ε3 genotype, by calculating study-specific and random effects pooled, unadjusted odds ratios ( ORs). RESULTS: Thirteen studies fulfilled inclusion criteria: 7 memory clinic cohorts (n = 2,587), 5 symptomatic CAA cohorts (n = 402), and 1 population-based study (n = 1,379). There was no significant overall association between APOE ε4+ and cSS presence or severity. When stratified by clinical setting, APOE ε4+ was associated with cSS in memory clinic (OR 2.10; 95% confidence interval [CI] 1.11-3.99) but not symptomatic CAA patients. The pooled OR showed significantly increased odds of having cSS for APOE ε2+ genotypes (OR 2.42, 95% CI 1.48-3.95) in both patient populations. This association was stronger for disseminated cSS in symptomatic CAA cohorts. In detailed subgroup analyses, APOE ε2/ε2 and APOE ε2/ε4 genotypes were most consistently and strongly associated with cSS presence and severity. CONCLUSION: CAA-related vasculopathic changes and fragility associated with APOE ε2+ allele might have a biologically meaningful role in the pathophysiology and severity of cSS.
|
Authors | Andreas Charidimou, Hazel I Zonneveld, Sara Shams, Kejal Kantarci, Ashkan Shoamanesh, Saima Hilal, Paul A Yates, Gregoire Boulouis, Han Kyu Na, Marco Pasi, Allesandro Biffi, Yuek Ling Chai, Joyce Ruifen Chong, Lars-Olof Wahlund, Jack R Clifford, Christopher Chen, M Edip Gurol, Joshua N Goldstein, Duk L Na, Frederik Barkhof, Sang Won Seo, Jonathan Rosand, Steven M Greenberg, Anand Viswanathan |
Journal | Neurology
(Neurology)
Vol. 93
Issue 4
Pg. e358-e371
(07 23 2019)
ISSN: 1526-632X [Electronic] United States |
PMID | 31243071
(Publication Type: Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2019 American Academy of Neurology. |
Chemical References |
- Apolipoprotein E2
- Apolipoprotein E3
- Apolipoprotein E4
- Apolipoproteins E
|
Topics |
- Apolipoprotein E2
- Apolipoprotein E3
- Apolipoprotein E4
- Apolipoproteins E
(genetics)
- Brain
(diagnostic imaging)
- Case-Control Studies
- Cerebral Amyloid Angiopathy
(diagnostic imaging)
- Cerebral Cortex
(diagnostic imaging, metabolism)
- Hemosiderosis
(diagnostic imaging, genetics)
- Humans
- Magnetic Resonance Imaging
- Odds Ratio
|